Dolutegravir-Lamivudine Dual Therapy in ARV-Naïve HIV Patients: 48-Week Results of PADDLE Trial

The PADDLE trial evaluated the efficacy, safety, and tolerability of a Dolutegravir-Lamivudine regimen as initial therapy in HIV-infected, treatment-naïve patients. This pilot study demonstrated comparable viral load changes to triple therapy, supporting the use of this dual regimen. The study desi

0 views • 13 slides